Relatively little is known about reproductive decision-making in women harboring mutations in the BRCA1 and/or BRCA2—pathogenic variants that confer different cancer risk profiles and underlie hereditary breast and ovarian cancer. Here, BRCA1 is linked to ovarian carcinoma.